![Min Fang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Min Fang
Director/Board Member at InSilico Medicine, Inc.
Min Fang active positions
Companies | Position | Start | End |
---|---|---|---|
InSilico Medicine, Inc.
![]() InSilico Medicine, Inc. Packaged SoftwareTechnology Services Part of InSilico Medicine Hong Kong Ltd., InSilico Medicine, Inc. is a clinical stage biotechnology company based in New York, NY. InSilico Medicine is focused on generative models, reinforcement learning, and other modern machine learning techniques for the generation of new molecular structures with specified parameters, generation of synthetic biological data, target identification, and prediction of clinical trials outcomes. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers, and other modern machine learning techniques for novel target discovery and the generation of novel molecular structures with desired properties. InSilico Medicine is developing breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases. The company was founded in 2014 by Aleksandr Aliper and Aleksandrs Zhavoronkov. Aleksandrs Zhavoronkov has been the CEO since 2014. | Director/Board Member | - | - |
Insilico Medicine Cayman TopCo
![]() Insilico Medicine Cayman TopCo Miscellaneous Commercial ServicesCommercial Services InSilico Medicine Cayman TopCo is a holding company, which engages in the research and development of generative artificial intelligence (AI) driven therapeutic pipeline and software licensing. Its pipeline targets areas include high unmet needs, with a footprint in fibrosis, oncology, immunology, and other therapeutic areas. The company was founded by Alex Zhavoronkov on November 19, 2018 and is headquartered in Hong Kong. | Director/Board Member | 01/06/2021 | - |
Career history of Min Fang
Former positions of Min Fang
Companies | Position | Start | End |
---|---|---|---|
HYGEIA HEALTHCARE HOLDINGS CO., LIMITED | Director/Board Member | 01/01/2020 | 01/10/2021 |
Training of Min Fang
Fudan University | Undergraduate Degree |
Stanford University | Masters Business Admin |
Statistics
International
United States | 3 |
Cayman Islands | 2 |
Hong Kong | 2 |
Operational
Director/Board Member | 3 |
Undergraduate Degree | 1 |
Masters Business Admin | 1 |
Sectoral
Consumer Services | 3 |
Technology Services | 2 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
HYGEIA HEALTHCARE HOLDINGS CO., LIMITED | Health Technology |
Private companies | 2 |
---|---|
InSilico Medicine, Inc.
![]() InSilico Medicine, Inc. Packaged SoftwareTechnology Services Part of InSilico Medicine Hong Kong Ltd., InSilico Medicine, Inc. is a clinical stage biotechnology company based in New York, NY. InSilico Medicine is focused on generative models, reinforcement learning, and other modern machine learning techniques for the generation of new molecular structures with specified parameters, generation of synthetic biological data, target identification, and prediction of clinical trials outcomes. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers, and other modern machine learning techniques for novel target discovery and the generation of novel molecular structures with desired properties. InSilico Medicine is developing breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases. The company was founded in 2014 by Aleksandr Aliper and Aleksandrs Zhavoronkov. Aleksandrs Zhavoronkov has been the CEO since 2014. | Technology Services |
Insilico Medicine Cayman TopCo
![]() Insilico Medicine Cayman TopCo Miscellaneous Commercial ServicesCommercial Services InSilico Medicine Cayman TopCo is a holding company, which engages in the research and development of generative artificial intelligence (AI) driven therapeutic pipeline and software licensing. Its pipeline targets areas include high unmet needs, with a footprint in fibrosis, oncology, immunology, and other therapeutic areas. The company was founded by Alex Zhavoronkov on November 19, 2018 and is headquartered in Hong Kong. | Commercial Services |
- Stock Market
- Insiders
- Min Fang
- Experience